Akt/cAMP-Responsive Element Binding Protein/Cyclin D1 Network: A Novel Target for Prostate Cancer Inhibition in Transgenic Adenocarcinoma of Mouse Prostate Model Mediated by Nexrutine, a <i>Phellodendron Amurense</i> Bark Extract
Addanki P. Kumar(The University of Texas Health Science Center at San Antonio), Rita Ghosh(Cancer Research Center)
Cited by 95
Related Papers
Inhibition of PI3K/AKT/mTOR axis disrupts oxidative stress-mediated survival of melanoma cells
|Oncotarget|2015|102
SETD6 regulates NF-κB signaling in urothelial cell survival: Implications for bladder cancer
|Oncotarget|2017|36
Crosstalk between RON and androgen receptor signaling in the development of castration resistant prostate cancer
|Oncotarget|2016|18
SIRT1 inhibition‐induced senescence as a strategy to prevent prostate cancer progression
|Molecular Carcinogenesis|2022|11